Zobrazeno 1 - 10
of 95
pro vyhledávání: '"M. Welnicka-Jaskiewicz"'
Autor:
Jarosław Skokowski, M. Welnicka-Jaskiewicz, Aleksandra Markiewicz, Anna Nagel, Barbara Seroczyńska, Tomasz Stokowy, Anna J. Zaczek, Jolanta Szade, Hanna Majewska
Publikováno v:
Translational Oncology, Vol 11, Iss 3, Pp 722-731 (2018)
Translational Oncology
Translational Oncology
Intratumoral heterogeneity of breast cancer remains a major challenge in successful treatment. Failure of cancer therapies can also be accredited to inability to systemically eradicate cancer stem cells (CSCs). Recent evidence points to the role of e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e31c6e16eb2ea76ebbc896293c81fb7
https://doi.org/10.1016/j.tranon.2018.03.006
https://doi.org/10.1016/j.tranon.2018.03.006
Autor:
Aleksandra Markiewicz, Jarosław Skokowski, Mariola Iliszko, Julia Elzanowska, Anna Nagel, Rafal Sadej, Grzegorz Stasiłojć, M. Welnicka-Jaskiewicz, Anna J. Zaczek, Jolanta Szade, Jacek Bigda
Publikováno v:
International Journal of Molecular Sciences
Volume 20
Issue 8
International Journal of Molecular Sciences, Vol 20, Iss 8, p 1881 (2019)
Volume 20
Issue 8
International Journal of Molecular Sciences, Vol 20, Iss 8, p 1881 (2019)
The amplification of estrogen receptor alpha (ER&alpha
) encoded by the ESR1 gene has been described as having a prognostic role in breast cancer patients. However, increased dosage of the ESR1 gene (tested by real-time PCR) is also observed in
) encoded by the ESR1 gene has been described as having a prognostic role in breast cancer patients. However, increased dosage of the ESR1 gene (tested by real-time PCR) is also observed in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7627b90f40133281f4952ea4c72a4372
Autor:
Tomasz Stokowy, Justyna Topa, Anna Nagel, Jarosław Skokowski, M. Welnicka-Jaskiewicz, Aleksandra Markiewicz, Barbara Seroczyńska, Anna J. Zaczek
Publikováno v:
Cancers
Volume 11
Issue 1
Volume 11
Issue 1
Circulating tumour cells (CTCs) can provide valuable prognostic information in a number of epithelial cancers. However, their detection is hampered due to their molecular heterogeneity, which can be induced by the epithelial-mesenchymal transition (E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e66bd5c0e8cf1d709d9ac4acbf2b8b4
http://europepmc.org/articles/PMC6356662
http://europepmc.org/articles/PMC6356662
Autor:
Laura Biganzoli, M. Welnicka-Jaskiewicz, Sandrine Marreaud, John M. S. Bartlett, Konstantinos Tryfonidis, Jan B. Vermorken, B. De Valk, Hussein M. Khaled, David Cameron, Jan Bogaerts, K Aalders
Publikováno v:
Breast cancer research and treatment
Tryfonidis, K, Marreaud, S, Khaled, H, De Valk, B, Vermorken, J, Welnicka-jaskiewicz, M, Aalders, K, Bartlett, J M S, Biganzoli, L, Bogaerts, J & Cameron, D 2017, ' Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 phase II study ', Breast cancer research and treatment . https://doi.org/10.1007/s10549-017-4203-y
Tryfonidis, K, Marreaud, S, Khaled, H, De Valk, B, Vermorken, J, Welnicka-jaskiewicz, M, Aalders, K, Bartlett, J M S, Biganzoli, L, Bogaerts, J & Cameron, D 2017, ' Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 phase II study ', Breast cancer research and treatment . https://doi.org/10.1007/s10549-017-4203-y
Cardiotoxicity is a side effect of trastuzumab. We assessed efficacy and cardiac safety of CMF with trastuzumab (CMF+T) in HER2-positive metastatic breast cancer patients (MBC). In this phase II study, centrally confirmed, previously treated HER2-pos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d7016532d42244f26e7ba31fe0bff0d
https://hdl.handle.net/10067/1442390151162165141
https://hdl.handle.net/10067/1442390151162165141
Autor:
Patrick Therasse, Jan Bogaerts, Tanja Cufer, Robert E. Coleman, Robert Paridaens, Peter Canney, Johan W. R. Nortier, Emiel J. Th. Rutgers, Jaroslaw Dyczka, Leilani Morales, M. Welnicka-Jaskiewicz
Publikováno v:
European Journal of Cancer. 43:331-340
Background The contribution of adjuvant tamoxifen in breast cancer patients after receiving adjuvant chemotherapy is not fully established. We investigated the impact of tamoxifen, given sequentially after completion of adjuvant chemotherapy in patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53fa40826fbe7a58155f2c0f9473ce2c
https://doi.org/10.1016/j.ejca.2006.10.009
https://doi.org/10.1016/j.ejca.2006.10.009
Autor:
Anna J. Zaczek, Burkhard Brandt, B Falkiewicz, P. Klos, M. Welnicka-Jaskiewicz, Nicola Tidow, Krzysztof P. Bielawski
Publikováno v:
The International Journal of Biological Markers. 20:184-188
The frequency of CA allele combinations was assessed in healthy women from Poland and compared to previously published polymorphism data of individuals from Germany and a Caucasian reference group. There were close similarities between these three ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aad70b8c1c3b883b4e25a4786c9a0271
https://doi.org/10.1177/172460080502000306
https://doi.org/10.1177/172460080502000306
Autor:
Tanja Cufer, Jaroslaw Dyczka, Fabio Efficace, Lois E. Shepherd, Michail R Lichinitser, Patrick Therasse, M. Welnicka-Jaskiewicz, Martine Piccart, Mirjam A. G. Sprangers, Andrew Bottomley, Corneel Coens, Kristel Van Steen, Hanneke C. J. M. de Haes
Publikováno v:
Journal of clinical oncology, 22(16), 3381-3388. American Society of Clinical Oncology
Purpose The purpose of this research was to evaluate whether baseline health-related quality of life (HRQOL) parameters are prognostic factors for survival in locally advanced breast cancer patients. Although the literature highlights the important r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b42bebf1edecd6b9b9cd95f99ab1e80
https://doi.org/10.1200/jco.2004.02.060
https://doi.org/10.1200/jco.2004.02.060
Autor:
M. Welnicka-Jaskiewicz, Jacek Jassem
Publikováno v:
Cancer Treatment Reviews. 29:355-361
For many years hormonal replacement therapy (HRT) has been considered to offer not only effective relief of climacteric symptoms but also a reduction in the risk of osteoporosis and cardiovascular disease, plus a possible prevention of cognitive decl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f1a312bbb06a6354e43478d84b81862
https://doi.org/10.1016/s0305-7372(03)00067-7
https://doi.org/10.1016/s0305-7372(03)00067-7
Autor:
L. Mauriac, Patrick Therasse, Tanja Cufer, Martine Piccart, Anne Hamilton, M. Welnicka-Jaskiewicz, Hervé Bonnefoi, Kathleen I. Pritchard, E Tomiak, Peter F. Bruning
Publikováno v:
Journal of Clinical Oncology. 21:843-850
Purpose: To compare the efficacy of a standard anthracycline-based regimen to a dose-intensified anthracycline regimen in locally advanced breast cancer. Patients and Methods: Locally advanced breast cancer patients were randomly assigned onto a stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42f27d21b32a089c95054f80c2e8b9d3
https://doi.org/10.1200/jco.2003.05.135
https://doi.org/10.1200/jco.2003.05.135
Autor:
Hanna Majewska, Anna J. Zaczek, Barbara Seroczyńska, Anna Nagel, Jolanta Szade, Jarosław Skokowski, M. Welnicka-Jaskiewicz, Aleksandra Markiewicz
Publikováno v:
Annals of Oncology. 28:vii32
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa31eb85ae62d5780a367b3b1a0ac820
https://doi.org/10.1093/annonc/mdx510.005
https://doi.org/10.1093/annonc/mdx510.005